The story of Viagra and its creator , copyright, presents a fascinating picture for potential investors. While the blockbuster drug initially produced enormous profits , its patent has expired , leading to generic alternatives flooding the market . This erosion in value presents a substantial obstacle for copyright and any fund considering a hea… Read More